Overview
The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers
Description
see brief summary
Eligibility
Inclusion Criteria:
- Patients with established or suspected (clinical and hematological criteria) VEXAS Syndrome
- Age ≥18 years
- Signed informed consent form
Exclusion Criteria:
- patients who are not in a position to understand the nature and scope of participation in this register